Revenue
2021
2022
2023
2024
Synbiotic SE (SBX)
Price—Loading quote
Net income
2021
2022
2023
2024
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue | €14.3M | €3.9M | €8.2M | €8.6M |
| Operating expenses | €15.4M | €12.5M | €28.5M | €16.2M |
| Operating income | −€10.5M | −€11.0M | −€24.9M | −€11.4M |
| Operating margin | −73.66% | −284.82% | −304.88% | −132.23% |
| EBITDA | −€2.0M | −€7.1M | −€7.5M | −€5.0M |
| EBITDA margin | −14.16% | −184.46% | −91.67% | −57.78% |
| Net income | −€9.7M | −€10.6M | −€24.4M | −€12.7M |
| Net profit margin | −67.92% | −275.31% | −298.35% | −147.13% |
| Basic EPSper basic share | -€1.66 | -€2.24 | -€5.97 | -€4.09 |
| Diluted EPSper diluted share | -€1.66 | -€2.24 | -€5.97 | -€4.09 |